camptothecin has been researched along with Encephalitis, JC Polyomavirus in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (88.89) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kameoka, M; Nakamichi, K; Nukuzuma, C; Nukuzuma, S; Sugiura, S; Takegami, T; Tasaki, T | 1 |
Ringelstein, EB; Vollmer-Haase, J; Young, P | 1 |
O'Reilly, S | 1 |
Smart, T | 2 |
Learned, J | 1 |
9 other study(ies) available for camptothecin and Encephalitis, JC Polyomavirus
Article | Year |
---|---|
CPT11 prevents virus replication in JCI cells persistently infected with JC polyomavirus.
Topics: Antiviral Agents; Camptothecin; Cell Line; Cell Proliferation; DNA Replication; DNA, Viral; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; JC Virus; Leukoencephalopathy, Progressive Multifocal; Naphthoquinones; Real-Time Polymerase Chain Reaction; Topoisomerase I Inhibitors; Topotecan; Viral Proteins; Virus Replication | 2017 |
Efficacy of camptothecin in progressive multifocal leucoencephalopathy.
Topics: Adult; Camptothecin; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Leukoencephalopathy, Progressive Multifocal; Lupus Erythematosus, Systemic; Topoisomerase I Inhibitors | 1997 |
Efficacy of camptothecin in progressive multifocal leucoencephalopathy.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Humans; Irinotecan; Leukoencephalopathy, Progressive Multifocal | 1997 |
PML and a tale of two drug companies.
Topics: AIDS-Related Opportunistic Infections; Albendazole; Blood-Brain Barrier; Camptothecin; Drug Industry; Humans; Irinotecan; JC Virus; Leukoencephalopathy, Progressive Multifocal; Microsporidiosis; Polymerase Chain Reaction; Topotecan | 1995 |
Topotecan now available for HIV, PML research.
Topics: Antineoplastic Agents; Camptothecin; HIV Infections; Humans; Leukoencephalopathy, Progressive Multifocal; Topotecan | 1995 |
Topotecan research moves forward at last.
Topics: Antineoplastic Agents; Antiviral Agents; Camptothecin; Clinical Trials as Topic; HIV Long Terminal Repeat; HIV-1; Humans; Leukoencephalopathy, Progressive Multifocal; Lymphoma; Mutation; Sarcoma, Kaposi; Topoisomerase I Inhibitors; Topotecan; Virus Replication | 1995 |
Making inroads on PML.
Topics: Acquired Immunodeficiency Syndrome; Camptothecin; HIV Protease Inhibitors; Humans; Irinotecan; Leukoencephalopathy, Progressive Multifocal; Topotecan | 1996 |
Topotecan and PML: the limits of pharmaceutical industry research.
Topics: AIDS-Related Opportunistic Infections; Antineoplastic Agents; Camptothecin; Clinical Trials, Phase II as Topic; Consumer Advocacy; Drug Approval; Drug Evaluation, Preclinical; Drug Industry; Health Services Accessibility; HIV Infections; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Ovarian Neoplasms; Topotecan | 1996 |
PML update.
Topics: Acquired Immunodeficiency Syndrome; Camptothecin; Clinical Trials, Phase II as Topic; Enzyme Inhibitors; Humans; Leukoencephalopathy, Progressive Multifocal; Topotecan | 1997 |